The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Vitiligo — Treatment Approaches

Modern stepwise management to repigment and stabilize this chronic autoimmune disorder.

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dermatoloji department. Book Appointment →

What is Vitiligo — Treatment Approaches?

Vitiligo is a chronic autoimmune disease in which CD8+ T cells driven by IFN-γ/CXCL9-10/CXCR3 signaling destroy melanocytes. The condition affects approximately 0.5–2% of the population worldwide, regardless of skin color, often appearing before age 30.

Two main subtypes are distinguished: non-segmental (most common, often symmetric, slowly progressive) and segmental (unilateral, follows a dermatomal pattern, typically stable after 1–2 years). The disease may be associated with autoimmune thyroiditis, alopecia areata, and type 1 diabetes.

Treatment is selected based on disease activity (Koebner phenomenon, confetti depigmentation, trichrome lesions), extent, location, and patient priorities. Goals are halting progression and inducing repigmentation.

Symptoms

Sharply demarcated milky-white macules and patches
Common sites: hands, periorificial face, lips, genitalia, knees, elbows, axillae, friction areas
Symmetrical pattern in non-segmental form; unilateral pattern in segmental form
White hairs (leukotrichia) within or around the patches
Koebner phenomenon (new lesions on traumatized skin)
Most patients have minimal physical symptoms but significant psychosocial impact

Risk Factors

Personal/family history of vitiligo or autoimmune disease
HLA associations (HLA-A*02:01, HLA-DRB1*04)
Other autoimmune disease: Hashimoto thyroiditis, Graves disease, alopecia areata, T1DM, pernicious anemia
Skin trauma (cuts, sunburn, friction)
Emotional stress, hormonal changes, chemical exposure (phenols, hydroquinone)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • New depigmented patches that are progressing in size or number
  • Lesions on visible areas (face, hands) impacting quality of life
  • Vitiligo associated with thyroid symptoms or other autoimmune disease
  • Suspected segmental vitiligo in a child for early surgical/medical planning

Treatment Methods

01
Topical calcineurin inhibitors (tacrolimus 0.1%, pimecrolimus 1%) for face, neck, and intertriginous areas
02
Topical corticosteroids (potent class) for body lesions, with periodic rest cycles
03
Topical ruxolitinib 1.5% cream — JAK1/2 inhibitor approved for non-segmental vitiligo, especially face
04
Narrowband UVB phototherapy (311 nm), 2–3 sessions/week — first-line for generalized disease
05
Excimer laser (308 nm) for localized disease
06
Systemic mini-pulse oral corticosteroids (e.g., dexamethasone) to halt rapid progression
07
Surgical melanocyte transfer (suction blister grafting, NCMS) for stable segmental vitiligo
08
Investigational/emerging: oral JAK inhibitors (ritlecitinib, baricitinib) for severe progressive disease
09
Photoprotection, treatment of associated autoimmunity, psychological support, camouflage cosmetics

Which Department to Visit?

You can visit our Dermatoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dermatoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Eczema (Atopic Dermatitis)

Dermatoloji

Atopic dermatitis is a chronic skin disease commonly seen especially in children, flaring with genetic predisposition and environmental triggers.

Psoriasis

Dermatoloji

Psoriasis is an autoimmune disease in which skin cells proliferate rapidly when the immune system mistakenly attacks the skin, leading to thick scaly lesions.

Acne

Dermatoloji

Acne is a skin disease resulting from clogging of hair follicles with oil and dead skin cells, commonly seen in adolescence but can occur at any age.

Rosacea

Dermatoloji

Rosacea is a chronic inflammatory facial skin disease characterized by recurrent flushing, persistent erythema, telangiectasia, and inflammatory papules and pustules. Phymatous change and ocular involvement may complicate advanced disease.

Urticaria (Hives)

Dermatoloji

Urticaria is a skin condition with sudden pink-red wheals and intense itching that may follow an acute or chronic course.

Skin Fungal Infections

Dermatoloji

Skin fungal infections are common, contagious skin diseases caused by dermatophytes and yeast fungi colonizing the upper layers of the skin.

Hair Loss (Alopecia)

Dermatoloji

Alopecia is a general term for hair loss that can be genetic, hormonal, autoimmune, or nutritional; early intervention can slow progression.

Vitiligo

Dermatoloji

Vitiligo is an acquired autoimmune disease in which CD8+ T cells destroy melanocytes, producing well-demarcated depigmented patches. Early, sustained treatment can induce repigmentation and prevent progression; psychosocial impact warrants holistic care.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.